Compare IOVA & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | NNN |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 7.9B |
| IPO Year | 2008 | 1995 |
| Metric | IOVA | NNN |
|---|---|---|
| Price | $8.34 | $41.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 18 |
| Target Price | $14.40 | ★ $46.25 |
| AVG Volume (30 Days) | ★ 12.3M | 2.7M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 5.97% |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ 1.01 |
| Revenue | N/A | ★ $926,213,000.00 |
| Revenue This Year | $56.63 | $5.77 |
| Revenue Next Year | $43.83 | $5.66 |
| P/E Ratio | ★ N/A | $40.97 |
| Revenue Growth | N/A | ★ 6.55 |
| 52 Week Low | $1.76 | $38.90 |
| 52 Week High | $15.37 | $50.00 |
| Indicator | IOVA | NNN |
|---|---|---|
| Relative Strength Index (RSI) | 29.97 | 47.01 |
| Support Level | $7.85 | $39.59 |
| Resistance Level | $9.36 | $45.52 |
| Average True Range (ATR) | 0.98 | 0.79 |
| MACD | -0.75 | 0.15 |
| Stochastic Oscillator | 1.76 | 44.04 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
NNN REIT Inc is a real estate investment trust that acquires, owns, invests in, and develops high-quality properties mainly leased under long-term net leases with minimal capital expenditure requirements. The company focuses mainly on retail properties, with a portfolio including convenience stores, automotive service properties, restaurants, theatres, entertainment venues, dealerships, and other retail-related assets. Primary business objectives emphasize retail properties, and it may invest in a wide variety of property and tenant types, leases, mortgages, loans secured by personal property, loans secured by partnership or membership interests, and securities of other REITs or other issuers.